Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891993 · ClinicalTrials.gov registry record · NA
Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer
A NA study of Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT02891993: Completed NA study of Cancer, sponsored by Massachusetts General Hospital.
NCT02891993 is a NA study of Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 150 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02891993, a NA study of Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.
Primary Outcome
To determine rates of participant completion of \>2 symptom reports, the investigators will assess the proportion of enrolled participants who complete of \>2 symptom reports.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER IMPROVED
Study Locations (1)
Massachusetts
- Massachusetts general Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-12-14 |
| Phase | NA |
What the finished NCT02891993 record still lists
NCT02891993 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT02891993 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02891993 about?
NCT02891993 is a clinical study titled "Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer". The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.
What is the current status of trial NCT02891993?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2016-09. Estimated completion is 2017-12-14.
What conditions does trial NCT02891993 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT02891993?
The interventions under investigation include: Usual Care (OTHER), IMPROVED (OTHER).
Who is sponsoring clinical trial NCT02891993?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02891993 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02891993's enrollment target sits among peer trials
150 264th of 615 higher than 346 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia